RESUMO
Research objective was to study the effectiveness of complex treatment of recurrent herpetic stomatitis with dysbiosis. The study included 147 patients aged from 18 to 45 years with recurrent herpetic stomatitis (RGS) and disbyosis divided in 3 groups. Group 1 received conventional antiviral and symptomatic treatment of RGS, in group 2 complex immunoglobulins (IgA (15-25%), IgM (15-25%) and Ig (50-70%)) were added to conventional therapy, group 3 received immunoglobulins only. Clinical and immunological efficiency was estimated by values of oral local immunity (SlgA, lysozyme), humoral immunity (IgE and IgG) and cellular immunity (RBTL with FGA, defined T-lymphocytes). Significant (p<0.05) increase of lisozyme and SlgA, RBTL with FGA, number of T-lymphocytes and IgG concentration was observed in group 2. The obtained data allow improving quality of treatment of recurrent herpetic stomatitis with related dysbiosis.
Assuntos
Disbiose/complicações , Estomatite Herpética/complicações , Estomatite Herpética/tratamento farmacológico , Adolescente , Adulto , Antivirais/uso terapêutico , Quimioterapia Combinada , Feminino , Humanos , Imunidade Celular , Imunoglobulina A/uso terapêutico , Imunoglobulina M/uso terapêutico , Contagem de Linfócitos , Masculino , Pessoa de Meia-Idade , Muramidase/análise , Recidiva , Saliva/enzimologia , Estomatite Herpética/imunologia , Linfócitos T/imunologia , Resultado do Tratamento , Adulto JovemRESUMO
Research objective was to study the efficacy of ingavirin for prevention of recurrent herpetic stomatitis in employees of Kazan city industrial enterprises frequently suffering from acute respiratory viral infections. 128 employees aged from 18 to 56 years were included in the study. Clinical and immunological efficiency of ingavirin prevention of recurrent herpetic stomatitis is proved by estimation of oral cavity local immunity (SlgA, lisozyme), humoral immunity (IgE and IgG) and cellular immunity (RBTL with FGA, defined T-lymphocytes). After administration of ingavirin significant (p<0.05) increase of lisozyme and SlgA, RBTL with FGA, number of T-lymphocytes and IgG concentration was observed. The obtained data allow to recommend ingavirin for prevention of recurrent herpetic stomatitis.
Assuntos
Caproatos/administração & dosagem , Imidazóis/administração & dosagem , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/virologia , Estomatite Herpética/epidemiologia , Estomatite Herpética/prevenção & controle , Doença Aguda , Adolescente , Adulto , Proteínas de Bactérias/análise , Proteínas de Bactérias/imunologia , Humanos , Imunoglobulina A/análise , Imunoglobulina G/análise , Indústrias , Ativação Linfocitária , Contagem de Linfócitos , Pessoa de Meia-Idade , Boca/imunologia , Muramidase/análise , Fito-Hemaglutininas/imunologia , Infecções Respiratórias/imunologia , Prevenção Secundária , Estomatite Herpética/imunologia , Linfócitos T/imunologia , Tartaristão/epidemiologia , Recursos Humanos , Adulto JovemRESUMO
In the study with participation of 96 children of 1-7 years age with recurrent herpetic stomatitis and allergic diseases therapeutic efficacy of Polioxidonium was investigated. Polioxidonium was used in combination with traditional methods and with He-Ne-laser irradiation. Local oral cavity immunity, indexes of cellular immunity (in the reaction of lymphocytes blast-transformation with phytohemagglutinin), indexes of humoral immunity (IgG and IgE) were studied, complement C(3)-component was determined. Polioxidonium in combination with traditional methods and with laser therapy for recurrent herpetic stomatitis treatment in children with allergic diseases influenced favourably upon clinical course of allergic diseases, let achieve stable remission, increased efficacy of their treatment, promoted immunological status and shorten the terms of medical rehabilitation.